Company Information

Background

SyntheticMR AB was founded in Linköping, Sweden in 2007 by Dr. Marcel Warntjes in order to commercialize a new magnetic resonance image processing methodology. Dr. Warntjes innovation was initially developed at the Center for Medical Image Science and Visualization (CMIV), Linköping, Sweden. The uniqueness in the technology is the quantification based approach which makes MR examinations both faster and more informative.

Today, the company´s products are based on the SyMRI technology, which offers a more efficient scanning and an increased reliability, since all protocols are available based on the same scan. SyMRI also offers a higher diagnostic quality, achieved through quantitative MR scanning and automated assistance in tissue characterization and volume estimation. Intuitive tools are provided to interact with the results and obtain a more quantitative diagnose.
The product SyMRI Diagnostics is CE-MDD marked.

A number of clinical evaluation projects of the SyMRI technology have been performed both within and outside Sweden and led to several publications which are described more in details under Clinical Studies. Currently the main focus is on neuro applications but activities have started to evaluate other applications such as knee imaging and breast screening.

SyntheticMR’s largest owner is Accelerator Nordic AB (publ), traded on the AktieTorget exchange in Stockholm, Sweden. Accelerator’s subsidiaries are active in major markets such as medical imaging, oncology and orthopedics.